I mentioned recently the safety concerns in regards to Avandia a diabetes medication manufactured by GlaxoSmithKline. Wired has an excellent article disambiguating why this drug would stay on the market despite the safety concerns and how potentially still unsafe drugs reach the market.
It is a good clear article, well worth the read: FDA Drug Standards: What's Safe Enough?
Thursday, August 02, 2007
Drug approval: what is safe enough
Posted by David Hunter at 7:36 pm
Labels: Pharma, Research Ethics
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment